189 related articles for article (PubMed ID: 34638384)
1. Evaluation of Comprehensive Gene Expression and NK Cell-Mediated Killing in Glioblastoma Cell Line-Derived Spheroids.
Morimoto T; Nakazawa T; Matsuda R; Nishimura F; Nakamura M; Yamada S; Nakagawa I; Park YS; Tsujimura T; Nakase H
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638384
[TBL] [Abstract][Full Text] [Related]
2. Antitumor Effects of Intravenous Natural Killer Cell Infusion in an Orthotopic Glioblastoma Xenograft Murine Model and Gene Expression Profile Analysis.
Morimoto T; Nakazawa T; Matsuda R; Maeoka R; Nishimura F; Nakamura M; Yamada S; Park YS; Tsujimura T; Nakagawa I
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397112
[TBL] [Abstract][Full Text] [Related]
3. Glioblastoma Stem-Like Cells Are More Susceptible Than Differentiated Cells to Natural Killer Cell Lysis Mediated Through Killer Immunoglobulin-Like Receptors-Human Leukocyte Antigen Ligand Mismatch and Activation Receptor-Ligand Interactions.
Haspels HN; Rahman MA; Joseph JV; Gras Navarro A; Chekenya M
Front Immunol; 2018; 9():1345. PubMed ID: 29967607
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Anti-KIR Antibody of 1-7F9 Attenuates the Antitumor Effects of Expanded and Activated Human Primary Natural Killer Cells on In Vitro Glioblastoma-like Cells and Orthotopic Tumors Derived Therefrom.
Maeoka R; Nakazawa T; Matsuda R; Morimoto T; Shida Y; Yamada S; Nishimura F; Nakamura M; Nakagawa I; Park YS; Tsujimura T; Nakase H
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762486
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment of Glioblastoma with Bortezomib Potentiates Natural Killer Cell Cytotoxicity through TRAIL/DR5 Mediated Apoptosis and Prolongs Animal Survival.
Gras Navarro A; Espedal H; Joseph JV; Trachsel-Moncho L; Bahador M; Gjertsen BT; Kristoffersen EK; Simonsen A; Miletic H; Enger PØ; Rahman MA; Chekenya M
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31319548
[No Abstract] [Full Text] [Related]
6. CIS deletion by CRISPR/Cas9 enhances human primary natural killer cell functions against allogeneic glioblastoma.
Nakazawa T; Morimoto T; Maeoka R; Matsuda R; Nakamura M; Nishimura F; Ouji N; Yamada S; Nakagawa I; Park YS; Ito T; Nakase H; Tsujimura T
J Exp Clin Cancer Res; 2023 Aug; 42(1):205. PubMed ID: 37563692
[TBL] [Abstract][Full Text] [Related]
7. ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma.
Zhang C; Burger MC; Jennewein L; Genßler S; Schönfeld K; Zeiner P; Hattingen E; Harter PN; Mittelbronn M; Tonn T; Steinbach JP; Wels WS
J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26640245
[TBL] [Abstract][Full Text] [Related]
8. Understanding glioblastoma stromal barriers against NK cell attack using tri-culture 3D spheroid model.
Heinrich MA; Huynh NT; Heinrich L; Prakash J
Heliyon; 2024 Feb; 10(3):e24808. PubMed ID: 38317968
[TBL] [Abstract][Full Text] [Related]
9. NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival.
Gras Navarro A; Kmiecik J; Leiss L; Zelkowski M; Engelsen A; Bruserud Ø; Zimmer J; Enger PØ; Chekenya M
J Immunol; 2014 Dec; 193(12):6192-206. PubMed ID: 25381437
[TBL] [Abstract][Full Text] [Related]
10. Hydrogel matrix presence and composition influence drug responses of encapsulated glioblastoma spheroids.
Hill L; Bruns J; Zustiak SP
Acta Biomater; 2021 Sep; 132():437-447. PubMed ID: 34010694
[TBL] [Abstract][Full Text] [Related]
11. Resistance to cytotoxicity and sustained release of interleukin-6 and interleukin-8 in the presence of decreased interferon-γ after differentiation of glioblastoma by human natural killer cells.
Kozlowska AK; Tseng HC; Kaur K; Topchyan P; Inagaki A; Bui VT; Kasahara N; Cacalano N; Jewett A
Cancer Immunol Immunother; 2016 Sep; 65(9):1085-97. PubMed ID: 27439500
[TBL] [Abstract][Full Text] [Related]
12. Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells.
Mukherjee S; Fried A; Hussaini R; White R; Baidoo J; Yalamanchi S; Banerjee P
J Exp Clin Cancer Res; 2018 Jul; 37(1):168. PubMed ID: 30041669
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity and infiltration of human NK cells in in vivo-like tumor spheroids.
Giannattasio A; Weil S; Kloess S; Ansari N; Stelzer EH; Cerwenka A; Steinle A; Koehl U; Koch J
BMC Cancer; 2015 May; 15():351. PubMed ID: 25933805
[TBL] [Abstract][Full Text] [Related]
14. Targeting and Therapy of Glioblastoma in a Mouse Model Using Exosomes Derived From Natural Killer Cells.
Zhu L; Oh JM; Gangadaran P; Kalimuthu S; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
Front Immunol; 2018; 9():824. PubMed ID: 29740437
[TBL] [Abstract][Full Text] [Related]
15. Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain.
Lee SJ; Kang WY; Yoon Y; Jin JY; Song HJ; Her JH; Kang SM; Hwang YK; Kang KJ; Joo KM; Nam DH
BMC Cancer; 2015 Dec; 15():1011. PubMed ID: 26704632
[TBL] [Abstract][Full Text] [Related]
16. Human U87 glioblastoma cells with stemness features display enhanced sensitivity to natural killer cell cytotoxicity through altered expression of NKG2D ligand.
Oh SJ; Yang JI; Kim O; Ahn EJ; Kang WD; Lee JH; Moon KS; Lee KH; Cho D
Cancer Cell Int; 2017; 17():22. PubMed ID: 28203118
[TBL] [Abstract][Full Text] [Related]
17. CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma.
Lupo KB; Matosevic S
J Hematol Oncol; 2020 Jun; 13(1):76. PubMed ID: 32532329
[TBL] [Abstract][Full Text] [Related]
18. Activated human primary NK cells efficiently kill colorectal cancer cells in 3D spheroid cultures irrespectively of the level of PD-L1 expression.
Lanuza PM; Vigueras A; Olivan S; Prats AC; Costas S; Llamazares G; Sanchez-Martinez D; Ayuso JM; Fernandez L; Ochoa I; Pardo J
Oncoimmunology; 2018; 7(4):e1395123. PubMed ID: 29632716
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours.
Shenouda MM; Gillgrass A; Nham T; Hogg R; Lee AJ; Chew MV; Shafaei M; Aarts C; Lee DA; Hassell J; Bane A; Dhesy-Thind S; Ashkar AA
Breast Cancer Res; 2017 Jul; 19(1):76. PubMed ID: 28668076
[TBL] [Abstract][Full Text] [Related]
20. Physical Characterization of Colorectal Cancer Spheroids and Evaluation of NK Cell Infiltration Through a Flow-Based Analysis.
Sargenti A; Musmeci F; Bacchi F; Delprete C; Cristaldi DA; Cannas F; Bonetti S; Pasqua S; Gazzola D; Costa D; Villa F; Zocchi MR; Poggi A
Front Immunol; 2020; 11():564887. PubMed ID: 33424829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]